Semustine is a drug used in chemotherapy.[1] It is structurally similar to lomustine, being distinguished from it only by an additional methyl group. It has been taken off the drug market for investigation of its cancerous effects, rated as IARC Group 1 carcinogen or a known carcinogen.[citation needed]
 | |
| Clinical data | |
|---|---|
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| UNII | |
| KEGG | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.162.271 |
| Chemical and physical data | |
| Formula | C10H18ClN3O2 |
| Molar mass | 247.72 g/mol g·mol−1 |
| (verify) | |
References
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |